Randomized, Double-Blind Clinical Evaluation of the Efficacy and Safety of Topical Eflornithine HCl 13.9% Cream in the Treatment of Women with Facial Hair

    July 2006 in “ International Journal of Dermatology ”
    John E. Wolf, Douglas Shander, Ferdinand Huber, Joseph Jackson, Chensheng Lin, Barbara Mathes, Kathy Schrode
    TLDR The cream effectively and safely reduces facial hair in women.
    The study conducted a randomized, double-blind clinical trial to evaluate the efficacy and safety of topical eflornithine HCl 13.9% cream for treating facial hair in women. The research involved a collaboration between Baylor College of Medicine, Gillette Advanced Technology Center, and Bristol-Myers Squibb. The results demonstrated that eflornithine HCl 13.9% cream was effective in reducing facial hair growth in women, providing a viable treatment option for this condition. The study also confirmed the safety of the cream, making it a promising solution for women seeking to manage unwanted facial hair.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    1 / 1 results

    Similar Research

    6 / 273 results
      Medical Treatment of Hirsutism

      research Medical Treatment of Hirsutism

      66 citations, September 2008 in “Dermatologic therapy”
      The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.
      Visually Scoring Hirsutism

      research Visually Scoring Hirsutism

      288 citations, June 2009 in “Human reproduction update”
      The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.
      Diagnosis and Management of Polycystic Ovary Syndrome (PCOS)

      research Diagnosis and Management of Polycystic Ovary Syndrome (PCOS)

      9 citations, January 2015 in “Springer eBooks”
      The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.
      Endocrine Evaluation of Hirsutism

      research Endocrine Evaluation of Hirsutism

      5 citations, June 2015 in “International Journal of Women's Dermatology”
      Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.
      Hirsutism

      research Hirsutism

      6 citations, April 2018 in “Obstetrics, gynaecology and reproductive medicine”
      Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.